Pheneturide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Pheneturide
Pheneturide.svg
Systematic (IUPAC) name
(RS)-N-carbamoyl-2-phenyl-butanamide
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
CAS Number 90-49-3 N
ATC code N03AX13 (WHO)
PubChem CID 72060
ChemSpider 65046 YesY
UNII 878CEJ4HGX YesY
KEGG D01190 YesY
Chemical data
Formula C11H14N2O2
Molar mass 206.241 g/mol
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Pheneturide (INN, BAN) (brand names Benuride, Deturid, Pheneturid, Septotence, Trinuride),[1] also known as phenylethylacetylurea (or ethylphenacemide), is an anticonvulsant of the ureide class.[2][3] It is considered to be obsolete,[4] and is now seldom used.[5] It is marketed in Europe, including in Poland, Spain, and the United Kingdom.[6] Pheneturide has a similar profile of anticonvulsant activity and toxicity relative to phenacemide,[7] but is less toxic in comparison, despite still being a toxic drug.[8] As such, it is only used in cases of severe epilepsy when other, less-toxic drugs have failed.[8] Pheneturide inhibits the metabolism and thus increases the levels of other anticonvulsants, such as phenytoin.[5][6]

See also[edit]

References[edit]

  1. ^ Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 998–. ISBN 978-3-7692-2114-5. 
  2. ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 959–. ISBN 978-1-4757-2085-3. 
  3. ^ Byrne B, Rothchild R (1999). "1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: applications to the anticonvulsant pheneturide". Chirality. 11 (7): 529–35. doi:10.1002/(SICI)1520-636X(1999)11:7<529::AID-CHIR3>3.0.CO;2-K. PMID 10423278. 
  4. ^ René H. Levy (2002). Antiepileptic Drugs. Lippincott Williams & Wilkins. pp. 210–. ISBN 978-0-7817-2321-3. 
  5. ^ a b M.J. Denham (6 December 2012). The Treatment of Medical Problems in the Elderly. Springer Science & Business Media. pp. 335–. ISBN 978-94-011-6223-4. 
  6. ^ a b Julius Vida (19 July 2013). Anticonvulsants. Elsevier. pp. 4,42. ISBN 978-0-323-14395-0. 
  7. ^ George deStevens; V. Zingel; C. Leschke; W. Schunack, Paul D. Hoeprich, Richard M. Schultz, P.K. Mehrotra, Sanjay Batra, A.P. Bhaduri, Anil K. Saxena, Mridula Saxena (11 November 2013). Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Birkhäuser. pp. 217–. ISBN 978-3-0348-7161-7.  Cite uses deprecated parameter |coauthors= (help)
  8. ^ a b Richard Lancaster (22 October 2013). Pharmacology in Clinical Practice. Elsevier. pp. 222–. ISBN 978-1-4831-9294-9.